The lack of differences in apelin between patients with AF and NSR in our study compared with those in other studies may reflect differences in overall disease progression, which might suggest that atrial apelin levels precede reductions in plasma levels depending on the underlying AF pathogenesis. This evidence concerns the gene APLN and atrial fibrillation.